Global Interferons Market, By Type (Alpha, Beta, Gamma, Others), Indication (Chronic Hepatitis, Leukemia, AIDS, Kaposi Sarcoma, Malignant Melanoma, Multiple Sclerosis, Chronic Granulomatous, Others), Route of Administration (Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Interferons Market Analysis and Size
The global interferons market is expected to witness significant growth during the forecast period. Interferons have proved to be a beneficial and successful treatment option for numerous illnesses such as cancer, hepatitis, and multiple sclerosis. Several big companies are working together to expand the growth of the market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global interferons market in the forecast period 2022-2029. The expected CAGR of global interferons market is tend to be around 4% in the mentioned forecast period. The market was valued at USD 7.61 billion in 2021, and it would grow upto USD 10.41 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Interferons are the type of protein that is produced or generated by the tumor cells in defense of pathogenic microbes such as fungi ,virus, bacteria, and other tumor cells. They have the capability to interfere with the viral cell replication and fight against the infection by generating an immune response leading to the production of immunogenic cells such as T-helper cells, macrophages and natural killer cells. They are used as first line agents against microbial infections. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period
Interferons Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Alpha, Beta, Gamma, Others), Indication (Chronic Hepatitis, Leukemia, AIDS, Kaposi Sarcoma, Malignant Melanoma, Multiple Sclerosis, Chronic Granulomatous, Others), Route of Administration (Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Johnson & Johnson Private Limited (U.S.), Abbott (U.S.), AbbVie Inc. (U.S.), Bausch Health Companies Inc. (Canada), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), Amneal Pharmaceuticals LLC. (U.S.), Pfizer Inc (U.S.), Mylan N.V. (U.S.), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (Germany), Merck KGaA (Germany)
|
|
Market Opportunities
|
|
Global Interferons Market Dynamics
Drivers
- Increased Drug Approvals
Growing number of approvals of interferon-beta by organizations such as the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Health Research Authority (HRA) is predicted to expand growth. For instance, SNG001, is an interferon-beta-1a inhalation formulation which is nebulized directly into the lungs. This boost the market growth.
- High Strategic Collaborations by Market Players
Major players are also focusing on expanding their presence with the help of multiple promotions, improved distribution networks, and enhanced customer services associated with their products to improve the brand and products. For instance, in March 2020, Bayer and Curadev signed a license agreement and research collaboration to manufacture a novel stimulator of interferon genes (STING) antagonists for many indications. It is well-known to activate the innate immune system in auto-inflammatory diseases. This boosts the growth of the market.
Opportunities
- Increased Research and Developments
Growing prevalence of cancer, hepatitis, and multiple sclerosis is creating a new opportunity for major market players to evaluate biosimilar clinical applications. With regards to this, numerous pharmaceutical companies are manufacturing interferon biosimilar medications to either compete or replace the original products. Increasing investments in R&D and ongoing technological advancements are some of the major factors contributing to growth in the global interferons market.
- Rising Healthcare Awareness
Health awareness amongst the population are rising which results in the prediction of drugs boost the market growth. The innovative launches in medications for the treatment of squamous cell carcinoma are expected to prompt the market simultaneously. Different researchers are investing on launching the drugs that are beneficial for the market.This creates more opportunity in the market.
Restraints/Challenges
- Lack of Skilled Professionals
Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global interferons market over a forecast period.
- High Cost
The huge expenditure of the treatment methods hamper the market growth. The development process of interferons is more expensive than chemically-derived small molecules. Also, it involves higher operating costs and requires a larger capital investment. It is attributed to the need for premium-quality manufacturing techniques as biologic medications are more complicated than small molecules.
This global interferons market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global interferons market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In May 2021, Sandoz, which is a subsidiary of Novartis declared the expansion of its production capabilities in Europe to support the European antibiotic manufacturing facility.
- In December 2021, Biogen and TheraPanacea signed a new collaboration agreement to expand digital health for personalized medicine in neuroscience.
Global Interferons Market Scope
The global interferons market is segmented on the basis of type, indication, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Alpha
- Beta
- Gamma
- Others
Indication
- Chronic Hepatitis
- Leukemia
- AIDS
- Kaposi Sarcoma
- Malignant Melanoma
- Multiple Sclerosis
- Chronic Granulomatous
- Others
Route of Administration
- Parenteral
- Others
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Interferons Market Regional Analysis/Insights
The global interferons market is analysed and market size insights and trends are provided by type, indication, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global interferons market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to the presence of key manufacture of the product, high research and development and healthcare expenditure and skilled professionals.
Asia-Pacific dominates the market due to increased government awareness programs and number of generic drugs.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Interferons Market Share Analysis
The global interferons market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global interferons market.
Key players operating in the global interferons market include:
- Johnson & Johnson Private Limited (U.S.)
- Abbott (U.S.)
- AbbVie Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
- Hikma Pharmaceuticals PLC (U.K.)
- Amneal Pharmaceuticals LLC. (U.S.)
- Pfizer Inc (U.S.)
- Mylan N.V. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Bayer AG (Germany)
- Merck KGaA (Germany)
SKU-